| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |